Saulo Euclides Silva-Filho

Prof. Dr. Saulo Euclides Silva-Filho

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
GCGabriel Fernando Esteves Cardia
Gabriel Fernando Esteves Cardia
SSSaulo Euclides Silva-Filho
Saulo Euclides Silva-Filho
ESExpedito Leite Silva
Expedito Leite Silva
NUNancy Sayuri Uchida
Nancy Sayuri Uchida
HCHeitor Augusto Otaviano Cavalcante
Heitor Augusto Otaviano Cavalcante
RCRoberto Kenji Nakamura Cuman
Roberto Kenji Nakamura Cuman
Lavandula angustifolia is a plant of Lamiaceae family, with many therapeutic properties and biological activities, such as anticonvulsant, anxiolytic, antioxidant, anti‐inflammatory, and antimicrobial activities. The aim of this study was to evaluate the effect of Lavandula angustifolia Mill. essential oil (LEO) on acute inflammatory response. LEO was analyzed using gas chromatography‐mass spectrometry (GC‐MS) and nuclear magnetic resonance spectroscopy (NMR) methods and showed predominance of 1,8‐cineole (39.83%), borneol (22.63%), and camphor (22.12%). LEO at concentrations of 0.5, 1, 3, and 10 μg/ml did not present in vitro cytotoxicity. Additionally, LEO did not stimulate the leukocyte chemotaxis in vitro. The LEO topical application at concentrations of 0.25, 0.5, and 1 mg/ear reduced edema formation, myeloperoxidase (MPO) activity, and nitric oxide (NO) production in croton oil‐induced ear edema model. In carrageenan‐induced paw edema model, LEO treatment at doses of 75, 100, and 250 mg/kg reduced edema formation, MPO activity, and NO production. In dextran‐induced paw edema model, LEO at doses of 75 and 100 mg/kg reduced paw edema and MPO activity. In conclusion, LEO presented anti‐inflammatory activity, and the mechanism proposed of LEO seems to be, at least in part, involving the participation of prostanoids, NO, proinflammatory cytokines, and histamine.

1 January 2017 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
NUNancy Sayuri Uchida
Nancy Sayuri Uchida
SSSaulo Euclides Silva-Filho
Saulo Euclides Silva-Filho
GCGabriel Fernando Esteves Cardia
Gabriel Fernando Esteves Cardia
ECEdivaldo Cremer
Edivaldo Cremer
FSFrancielli Maria De Souza Silva-Comar
Francielli Maria De Souza Silva-Comar
RCRoberto Kenji Nakamura Cuman
Roberto Kenji Nakamura Cuman
High doses of acetaminophen (APAP) lead to acute liver damage. In this study, we evaluated the effects of citral in a murine model of hepatotoxicity induced by APAP. The liver function markers alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and gamma‐glutamyl transferase (γGT) were determined to evaluate the hepatoprotective effects of citral. The livers were used to determine myeloperoxidase (MPO) activity and nitric oxide (NO) production and in histological analysis. The effect of citral on leukocyte migration and antioxidant activity was evaluated in vitro. Citral pretreatment decreased significantly the levels of ALT, AST, ALP, and γGT, MPO activity, and NO production. The histopathological analysis showed an improvement of hepatic lesions in mice after citral pretreatment. Citral inhibited neutrophil migration and exhibited antioxidant activity. Our results suggest that citral protects the liver against liver toxicity induced by APAP.

1 April 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
EPElisangela dos Santos Procopio
Elisangela dos Santos Procopio
MLMaicon Matos Leitão
Maicon Matos Leitão
CICaren Naomi Aguero Ito
Caren Naomi Aguero Ito
SSSaulo Euclides Silva-Filho
Saulo Euclides Silva-Filho
AAArielle Cristina Arena
Arielle Cristina Arena
CKCandida Kassuya
Candida Kassuya

1 March 2020 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
ÂKÂngela Midori Kuraoka-Oliveira
Ângela Midori Kuraoka-Oliveira
JRJoyce Alencar Santos Radai
Joyce Alencar Santos Radai
MLMaicon Matos Leitão
Maicon Matos Leitão
Claudia Andrea Lima CardosoClaudia Andrea Lima Cardoso
Claudia Andrea Lima Cardoso
SSSaulo Euclides Silva-Filho
Saulo Euclides Silva-Filho
CKCandida Kassuya
Candida Kassuya

1 December 2016 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
SSSaulo Euclides Silva-Filho
Saulo Euclides Silva-Filho
LWLuiz Alexandre Marques Wiirzler
Luiz Alexandre Marques Wiirzler
HCHeitor Augusto Otaviano Cavalcante
Heitor Augusto Otaviano Cavalcante
NUNancy Sayuri Uchida
Nancy Sayuri Uchida
FSFrancielli Maria de Souza Silva-Comar
Francielli Maria de Souza Silva-Comar
RCRoberto Kenji Nakamura Cuman
Roberto Kenji Nakamura Cuman

12 February 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Gustavo Villas-BoasGustavo Villas-Boas
Gustavo Villas-Boas
SLSTEFANIA LAVORATO
STEFANIA LAVORATO
MPMarina Meirelles Paes
Marina Meirelles Paes
PCPablinny M. G. de Carvalho
Pablinny M. G. de Carvalho
VRVanessa C. Rescia
Vanessa C. Rescia
SOSilvia Oesterreich
Silvia Oesterreich
Serotonin (5-HT) receptors are found throughout central and peripheral nervous systems, mainly in brain regions involved in the neurobiology of anxiety and depression. 5-HT receptors are currently promising targets for discovering new drugs for treating disorders ranging from migraine to neuropsychiatric upsets, such as anxiety and depression. It is well described in the current literature that the brain expresses seven types of 5-HT receptors comprising eighteen distinct subtypes. In this article, we comprehensively reviewed 5-HT1-7 receptors. Of the eighteen 5-HT receptors known today, thirteen are G protein-coupled receptors (GPCRs) and represent targets for approximately 40% of drugs used in humans. Signaling pathways related to these receptors play a crucial role in neurodevelopment and can be modulated to develop effective therapies to treat anxiety and depression. This review presents the experimental evidence of the modulation of the “serotonergic receptosome” in the treatment of anxiety and depression, as well as demonstrating state-of-the-art research related to phytochemicals and these disorders. In addition, detailed aspects of the pharmacological mechanism of action of all currently known 5-HT receptor families were reviewed. From this review, it will be possible to direct the rational design of drugs towards new therapies that involve signaling via 5-HT receptors.